Quantitative MRI assessment of treatment response using advanced novel imaging techniques have shown promises for monitoring outcome in patients with symptomatic multiple myeloma (MM), undergoing intensive chemotherapy.
In this work we are investiagting the potential of whole-body mDixon MRI's signal fat fraction early changes as a prognostic imaging biomarker for long-term follow-up of MM patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords